Stock Analysis

DCF Gap Between Modeled Value And Share Price Might Change The Case For Investing In Coca-Cola FEMSA. de (KOF)

  • Recent analysis using a two-stage discounted cash flow model estimated Coca-Cola FEMSA’s fair value at about US$163 per share, compared with a current market price of around US$90.50, highlighting a wide gap between modeled intrinsic value and trading levels observed in recent days.
  • This valuation work draws attention to how sensitive Coca-Cola FEMSA’s perceived worth can be to assumptions about discount rates and long-term cash flow growth, potentially encouraging investors to re-examine their own models and the company’s underlying cash generation.
  • We’ll now examine how this apparent gap between discounted cash flow estimates and market pricing could influence Coca-Cola FEMSA’s broader investment narrative.

These 13 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.

Advertisement

Coca-Cola FEMSA. de Investment Narrative Recap

To own Coca-Cola FEMSA, you need to believe in steady beverage demand across Latin America and the company’s ability to protect margins despite FX volatility and soft spots in Mexico and Brazil. The recent DCF-based fair value estimate around US$163 per share, far above the roughly US$90.50 market price, has no direct effect on operations, but it could sharpen focus on whether macro headwinds and competitive pressure are being over or underpriced in the short term.

Among recent announcements, the board’s proposal and subsequent affirmations of higher dividends through 2025 stand out alongside this DCF work. While cash returns can support the investment case around resilient cash generation, they also bring the company’s ability to balance shareholder payouts with reinvestment needs and margin pressures into clearer focus at a time when investors are closely watching earnings sensitivity to regional economic conditions.

Yet, against this apparent value gap, investors should be aware of the earnings impact that sustained FX volatility across key markets could...

Read the full narrative on Coca-Cola FEMSA. de (it's free!)

Coca-Cola FEMSA. de's narrative projects MX$349.2 billion revenue and MX$29.6 billion earnings by 2028. This requires 6.5% yearly revenue growth and a MX$6.0 billion earnings increase from MX$23.6 billion today.

Uncover how Coca-Cola FEMSA. de's forecasts yield a $110.03 fair value, a 20% upside to its current price.

Exploring Other Perspectives

KOF 1-Year Stock Price Chart
KOF 1-Year Stock Price Chart

Nine fair value estimates from the Simply Wall St Community span roughly US$85.72 to US$181.15, underscoring how far opinions can diverge. You can weigh those views against the risk that FX volatility and weaker local economies pressure Coca-Cola FEMSA’s earnings and reshape expectations for its future performance.

Explore 9 other fair value estimates on Coca-Cola FEMSA. de - why the stock might be worth 7% less than the current price!

Build Your Own Coca-Cola FEMSA. de Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

Seeking Other Investments?

Our top stock finds are flying under the radar-for now. Get in early:

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NYSE:KOF

Coca-Cola FEMSA. de

A franchise bottler, produces, markets, sells, and distributes Coca-Cola trademark beverages in Mexico, Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Brazil, Argentina, and Uruguay.

Undervalued with excellent balance sheet and pays a dividend.

Advertisement

Weekly Picks

RO
RockeTeller
SCZ logo
RockeTeller on Santacruz Silver Mining ·

Crazy Undervalued 42 Baggers Silver Play (Active & Running Mine)

Fair Value:CA$8696.7% undervalued
74 users have followed this narrative
7 users have commented on this narrative
21 users have liked this narrative
RO
Robbo
FID logo
Robbo on Fiducian Group ·

Fiducian: Compliance Clouds or Value Opportunity?

Fair Value:AU$121.2% undervalued
13 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative
WO
WVVI logo
woodworthfund on Willamette Valley Vineyards ·

Willamette Valley Vineyards (WVVI): Not-So-Great Value

Fair Value:US$245.0% overvalued
11 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative

Updated Narratives

NO
S5L logo
Norms70 on Standard Lithium ·

SLI is share to watch next 5 years

Fair Value:€4.59.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DA
davidlsander
BEAM logo
davidlsander on Beam Therapeutics ·

The "Molecular Pencil": Why Beam's Technology is Built to Win

Fair Value:US$15081.9% undervalued
59 users have followed this narrative
3 users have commented on this narrative
0 users have liked this narrative
RE
PRME logo
RedhawkCC on Prime Medicine ·

PRME remains a long shot but publication in the New England Journal of Medicine helps.

Fair Value:US$0.0469.1k% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

TH
TheWallstreetKing
MVIS logo
TheWallstreetKing on MicroVision ·

MicroVision will explode future revenue by 380.37% with a vision towards success

Fair Value:US$6098.5% undervalued
118 users have followed this narrative
11 users have commented on this narrative
22 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$250.3925.9% undervalued
962 users have followed this narrative
6 users have commented on this narrative
25 users have liked this narrative
RO
RockeTeller
SCZ logo
RockeTeller on Santacruz Silver Mining ·

Crazy Undervalued 42 Baggers Silver Play (Active & Running Mine)

Fair Value:CA$8696.7% undervalued
74 users have followed this narrative
7 users have commented on this narrative
21 users have liked this narrative